Emergent BioSolutions Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
Good day, everybody, and thank you for joining us at the Bank of America Virtual Healthcare Conference. My name is Jason Gerberry. I cover pharma and biotech at BofA, and I am pleased to be introducing our next company presenter, Emergent BioSolutions Richard Lindahl, Executive Vice President and Chief Financial Officer of Emergent. Emergent is a specialty biopharma company focused on the development of vaccines and therapeutics for infectious diseases and opioid overdoses and much more. But Rich, thank you so much for joining us at the conference. I believe you have a presentation that you're going to walk investors through, and I'll hand it over to you.
All right. Thank you very much, Jason, and good morning, everyone. Thank you very much for joining our presentation today. I look forward to sharing the highlights of the Emergent BioSolutions story with you this morning.
I am -- I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
